Immune to Cancer: The CRI Blog
-
ASCO18 Update: Much Ado About Melanoma (and Lung Cancer, Too)
Day 4 of ASCO18 focused on the past, present, and future of melanoma treatment, and also revealed…
-
ASCO18 Update: Immunotherapy Progress in Lung Cancer, New Promise in Ovarian Cancer
Day 3 of ASCO18 revealed more of immunotherapy’s benefits in lung cancer, especially as a first-line option,…
-
ASCO18 Update: Enhancing the Immune System’s Power Through Combination Therapies
Day 2 of ASCO18 highlighted a number of combinations and novel agents that aimed to improve immunotherapy’s…
-
ASCO18 Update: Vaccines, CAR T Cells, and OX40 Checkpoint Therapy
The first day of ASCO18 highlighted diverse immunotherapies, including vaccines, CAR T cells, and novel checkpoint drugs
-
30 Days of CRI Impact
Throughout Cancer Immunotherapy Month in June we’ll be highlighting the 30 most important CRI-funded breakthroughs.
-
ASCO18: Delivering Discoveries – Expanding the Reach of Precision Medicine
The world’s largest clinical cancer conference returns to Chicago June 1-5
-
Creating for the Cure: An Epic Podcast Fundraising Event
This year’s Livestream for the Cure podcast event lasted 30 hours and raised over $5,000 for cancer research,…
-
Jenny’s Immunotherapy Story
Lymphoma There’s life during cancer, too. Especially when I was doing immunotherapy. Jenny’s Story Jenny was still… -
Jami’s Immunotherapy Story
Lymphoma | Diagnosed 1994 In my history of cancer treatments, I’ve had to be really persistent to stay…
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.